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Vascular network engineering is essential for nutrient delivery to tissue-engineered 
constructs and, consequently, their survival. In addition, the functionality of tissues also 
depends on tissue drainage and immune cell accessibility, which are the main functions 
of the lymphatic system. Engineering both the blood and lymphatic microvasculature 
would advance the survival and functionality of tissue-engineered constructs. The aim 
of this study was to isolate pure populations of lymphatic endothelial cells (LEC) and 
blood vascular endothelial cells (BEC) from human dermal microvascular endothelial 
cells and to study their network formation in our previously described coculture model 
with adipose-derived stromal cells (ASC) in fibrin scaffolds. We could follow the network 
development over a period of 4 weeks by fluorescently labeling the cells. We show that 
LEC and BEC form separate networks, which are morphologically distinguishable and 
sustainable over several weeks. In addition, lymphatic network development was depen-
dent on vascular endothelial growth factor (VEGF)-C, resulting in denser networks with 
increasing VEGF-C concentration. Finally, we confirm the necessity of cell–cell contact 
between endothelial cells and ASC for the formation of both blood and lymphatic micro-
vascular networks. This model represents a valuable platform for in vitro drug testing and 
for the future in vivo studies on lymphatic and blood microvascularization.
Keywords: lymphatics, endothelial cells, coculture, fibrin, tissue engineering
inTrODUcTiOn
Survival of tissue-engineered constructs following implantation is inherently dependent on adequate 
oxygen and nutrient supply. The diffusion range of oxygen is generally limited to ~200 μm (Carmeliet 
and Jain, 2000), meaning that thick tissues require a vascular network to deliver a sufficient amount 
of nutrients and, thus, promote cell survival (Frerich et  al., 2001; Costa-Almeida et  al., 2014). 
Consequently, adequate oxygen and nutrient supply is a prerequisite for survival of tissue-engineered 
constructs in vivo. Therefore, the success of scaffold inclusion relies greatly on efficient vasculariza-
tion. While a lot of attention has been dedicated to the engineering of blood vasculature, substantially 
fewer studies have focused on the engineering of lymphatic vessels. Lymphatic research gained a 
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boost with the identification of markers that distinguish blood 
and lymphatic endothelial cells (LEC) [blood vascular endothe-
lial cells (BEC) and LEC, respectively]. The lymphatic system is 
an essential component of nearly all tissues; its main functions 
being drainage and recycling of interstitial fluid, and immune cell 
and lipid transport (Tammela and Alitalo, 2010). Tissues with 
damaged lymphatic networks are characterized by lymphedema 
and persistent infections (Petrek et al., 2001; Beesley et al., 2007; 
Hayes et al., 2008; Weitman et al., 2013). Consequently, incorpo-
ration of a lymphatic network into tissue-engineered constructs 
is likely to improve their integration and functionality in vivo by 
enabling appropriate tissue drainage and substantial immune cell 
accessibility.
A large body of research has focused on overcoming the 
issue of insufficient vascularization (Rouwkema et  al., 2008; 
Baldwin et al., 2014). Pre-vascularization strategies assume the 
development of a vascular network in vitro prior to implantation 
of the tissue-engineered construct. Coculturing endothelial 
cells together with supporting cells was shown to result in the 
formation of a vascular network in  vitro (Rivron et  al., 2008; 
Baldwin et al., 2014; Costa-Almeida et al., 2014). Furthermore, 
supporting cells are needed for stabilization of the vessels in 
networks, and for the restriction of permeability and prevention 
of vessel regression (Kunz-Schughart et al., 2006; Rivron et al., 
2008; Duttenhoefer et al., 2013). The supporting cells most com-
monly used include fibroblasts (Grainger and Putnam, 2011), 
mesenchymal stromal cells, such as adipose-derived stromal cells 
(ASC) and bone marrow-derived stromal cells [reviewed by Pill 
et  al. (2015)], and smooth muscle cells (Elbjeirami and West, 
2006). A source of endothelial cells commonly used is human 
umbilical vein endothelial cells (HUVEC) (Siow, 2012), which 
have been shown to form vascular networks when cocultured 
with supporting cell types in vitro (Sorrell et al., 2007; Verseijden 
et al., 2010a; Holnthoner et al., 2015). On the other hand, human 
dermal microvascular endothelial cells (HDMEC) represent a 
more appealing source, since the majority of endothelial cells 
in a human body are found in microvascular structures, mak-
ing this cell type suitable for studying many physiological and 
pathological conditions (Hewett and Murray, 1993). These cells 
have also been found to form vascular networks when cocultured 
with mural cells (Sorrell et al., 2007; Unger et al., 2010), but their 
behavior resembles that of in vivo cells more closely than it does of 
HUVEC (Swerlick et al., 1991; Cornelius et al., 1995). In addition 
to being a valuable source of BEC, HDMEC also contain LEC 
(Kriehuber et al., 2001; Marino et al., 2014; Gibot et al., 2016). For 
a potential clinical application, circulating endothelial colony-
forming cells (ECFC) are a promising source of BEC, since they 
can be isolated from peripheral blood (Siow, 2012) and show 
tube-forming capacity and the ability to form vascular networks 
in vitro (Fuchs et al., 2009; Medina et al., 2010; Holnthoner et al., 
2015). Moreover, they have been shown to contain a subset of 
lymphatic ECFC (DiMaio et al., 2016) and could also offer the 
possibility of engineering an autologous vascular network for 
future clinical use.
A few approaches for lymphatic tissue engineering have 
been developed in response to the necessity for tissue drainage 
and immune cell surveillance of tissue constructs (Schaupper 
et  al., 2016). Lymphatic capillary-like structures, for example, 
were established in collagen and fibrin matrices with interstitial 
flow applied (Helm et  al., 2007). Similarly, lymphatic capillary 
formation was achieved in a skin regeneration model implanted 
into mouse tails, simulating the influence of interstitial flow 
(Boardman and Swartz, 2003). Lymphatic capillaries were suc-
cessfully formed in fibrin-collagen hydrogels and integrated into 
a rat model of dermo-epidermal skin grafts (Marino et al., 2014). 
Another model shows the development of lymphatic capillaries in 
an in vitro scaffold-free three-dimensional (3D) coculture of LEC 
and fibroblasts (Gibot et al., 2016).
The functionality of tissue-engineered constructs could be 
greatly improved by the simultaneous engineering of a lymphatic 
vascular network as well as a blood vascular network. The aim of 
this study was to investigate the network-forming capacities of 
the two endothelial cell populations isolated from the HDMEC 
population and to explore the differences between the two cell 
types in vascular network formation in  vitro. Consequently, 
we have established a 3D coculture model consisting of ASC 
and fluorescently labeled LEC and BEC in fibrin hydrogels and 
showed the effect of vascular endothelial growth factor (VEGF)-C 
and supporting cells on the development of blood and lymphatic 
networks.
MaTerials anD MeThODs
cell culture and isolation
The isolation of human ASC was approved by the ethics com-
mittee of the state of Upper Austria (#200). ASC were obtained 
from liposuction materials as described previously (Wolbank 
et  al., 2007) and cultured in Endothelial Cell Growth Medium 
(EGM™-2 BulletKit™, Lonza) supplemented with additional 
FCS (Sigma-Aldrich, St. Louis, MO, USA) to a final concentration 
of 5% (referred to as EGM-2 unless stated otherwise). The cells 
were used in passages 2–10. HDMEC were isolated from human 
foreskin, according to protocol described previously (Schimek 
et al., 2013). Juvenile prepuce was obtained in compliance with the 
relevant laws, with informed consent and ethics approval (Ethic 
Committee Charité University Medicine, Berlin, Germany), 
from a pediatric surgery after routine circumcisions. LEC were 
isolated from HDMEC populations using immunomagnetic 
cell sorting with anti-podoplanin antibody and magnetic beads 
(Dynabeads, M280 goat anti-rabbit, ThermoFisher), follow-
ing the manufacturer’s instructions. The podoplanin-negative 
population, representing BEC, were obtained from the negative 
fraction by a second negative immunomagnetic selection with 
anti-podoplanin antibody, to remove the remaining podoplanin 
positive cells. BEC were cultured in EGM-2 medium, while LEC 
were propagated in EGM-2 medium supplemented with 50 ng/
mL VEGF-C. All cells derived from HDMEC were used between 
passages 6 and 9.
Plasmids and retroviral infection
Isolated LEC and BEC populations were retrovirally infected with 
fluorescent proteins to visualize network formation. The cDNA 
encoding pLV-EGFP, pLV-mCherry, and pBMN-Z was purchased 
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from Addgene (Cambridge, MA, USA). The pcDNA3-EYFP-HIS 
was purchased from Invitrogen (ThermoFisher, Waltham, MA, 
USA). The eGFP and mCherry were subcloned into the pBMN 
backbone after digestion with BamHI and SalI. The EYFP-HIS 
was subcloned into pBMN after digestion with BamHI and 
EcoRI. Phoenix Ampho cells were a kind gift from Regina Grillari 
(University of Natural Resources and Life Sciences, Vienna, 
Austria) and cultured in DMEM 10% FCS. Virus particle genera-
tion was performed by transfecting Phoenix cells at 80% conflu-
ency using Lipofectamine 2000 or TurboFect (ThermoFisher, 
Waltham, MA, USA), following the manufacturer’s instructions. 
The supernatants containing virus particles were transferred onto 
80% confluent LEC and BEC, and virus particles were centrifuged 
onto the cells at 800 × g for 60 min. The supernatant was then 
removed, and the cells were incubated overnight in EGM-2. 
Retrovirally infected cells were then expanded in new flasks and 
used for subsequent experiments.
Two-dimensional (2D) cocultures
Two-dimensional cocultures were prepared in 8-well chamber 
slides by seeding a total number of 48,000 cells/well. The cultures 
prepared contained equal ratios of ASC, LEC, and BEC, cultured 
in EGM-2 medium, with or without VEGF-C (25 ng/mL).
embedding of the cells in Fibrin Matrices
Fibrin matrix was prepared, as described elsewhere (Rohringer 
et  al., 2014), to address the question whether lymphatic capil-
laries can be built within the fibrin hydrogel. LEC and BEC used 
in these cultures were fluorescently labeled as described above. 
Briefly, 3D matrices were prepared on 15-mm diameter round 
coverslips (Paul Marienfeld, Lauda Königshofen, Germany) and 
are subsequently referred to as “clots.” The clots were prepared by 
diluting thrombin (human thrombin 4, Baxter, Vienna, Austria; 
4 U/mL) 1:10 in calcium chloride (CaCl2, Baxter, Vienna, Austria 
or Fresenius Kabi GmbH, Graz, Austria; 40 µmol/mL solution), 
and fibrinogen (Baxter, Vienna, Austria; 100  mg/mL) 1:20 in 
EGM-2. A total of 100,000 cells/cell type were used in each clot. 
The clot suspension contained a final concentration of 0.2 U/mL 
thrombin and 2.5 mg/mL fibrinogen. All clots were prepared in 
duplicate. After placing the suspensions on the cover slides, the 
clots were incubated for 20  min at 37°C prior to the addition 
of medium. An amount of 2 mL of EGM-2 medium or EGM-2 
medium supplemented with VEGF-C at indicated concentrations 
was added to the clots and exchanged every 2–3 days.
lec and Bec 3D cocultures with Varying 
VegF-c
Either LEC or BEC were cocultured with ASC and placed into 
fibrin matrices, as indicated above. Clots were cultured in EGM-2 
with different VEGF-C concentrations (0, 10, 25, and 50 ng/mL). 
Fluorescence images of the cultures were taken once a week for 
4 weeks.
lec and Bec 3D Tricultures
Lymphatic endothelial cells and BEC were embedded in fibrin 
matrices, as indicated above and cultured separately (with or 
without ASC) or together (with or without ASC) in EGM-2 or, 
for LEC, in EGM-2 medium containing VEGF-C (25 ng/mL). The 
cultures were photographed once a week for 4 weeks.
generation of asc-conditioned Medium 
(asc-cM) and 3D coculture
A total of 100,000 ASC were seeded in a tissue culture flask with 
the surface area of 75 cm2. The cells were cultured for 48 h prior 
to the removal of supernatant. The supernatant was removed 
and centrifuged for 15 min at 500 × g. The cells were then split 
and cultured for the next supernatant generation. As a control, 
EGM-2 medium was incubated in a tissue culture flask for the 
same time period as the ASC-CM. The 3D fibrin matrices were 
prepared as indicated earlier. LEC and BEC were cultured alone 
or with ASC. When cultured alone, the cells were either incubated 
in control EGM-2 medium or with ASC-conditioned EGM-2 
medium (2  mL/clot). When cultured with ASC, the cells were 
cultured in a 1:1 ratio (100,000 cells of each) and grown in EGM-2 
medium. When indicated, the medium was supplemented with 
VEGF-C at a concentration of 25 ng/mL. Images of the cultures 
were taken once a week.
network Quantification
The images were first processed in ImageJ software. The networks 
were quantified using Adobe Photoshop (Adobe Systems, San 
Jose, CA, USA) and Angiosys (Buckingham, UK) software. The 
standardization of images was performed in Adobe Photoshop, as 
described previously (Charwat et al., 2015). Briefly, the images of 
the LEC and BEC 3D tricultures were taken after 7 days from four 
different positions in each clot. One image was taken from each 
sample (including the duplicates) for three separate experiments 
(with cells from three donors) at day 28 for the quantification of 
the LEC networks at different VEGF-C concentrations.
antibodies and Flow cytometry
Antibodies used in flow cytometry measurements were as fol-
lows: anti-rabbit PE (Poly4064) and anti-mouse PE (Poly4053) 
from BioLegend (San Diego, CA, USA); mouse antihuman 
podoplanin from Santa Cruz Biotechnology (Dallas, TX, USA); 
rabbit antihuman podoplanin, rabbit antihuman LYVE-1, and 
mouse antihuman vascular endothelial growth factor receptor 
3 (VEGFR3) from Reliatech (Wolfenbüttel, Germany); and 
anti-rabbit and anti-mouse Alexa Fluor 488 from ThermoFisher 
Scientific (Waltham, MA, USA). The analysis was performed on 
a Beckman Coulter CytoFlex Flow Cytometer (Brea, CA, USA), 
and the data were analyzed using FlowJo software (FlowJo LLC, 
Ashland, OR, USA).
statistical analysis
The statistical analysis for LEC and BEC cocultures was per-
formed with GraphPad software using the Student’s t-test, with a 
level of significance set at p < 0.05. The data were logarithmically 
transformed and statistical analysis performed using one-way 
ANOVA with Dunnett’s post hoc analysis for the quantification 
of the networks at different VEGF-C concentrations. Level of 
significance was set at p < 0.05.
FigUre 1 | schematic representation of the separation of human dermal microvascular endothelial cells (hDMec) into lymphatic endothelial cells 
(lec) and blood vascular endothelial cells (Bec). Scale bar represents 100 µm. (a) Brightfield microscopy image of HDMEC before MACS with representative 
FACS plot showing the presence of podoplanin-positive cells. Arrows indicate LEC islands within BEC populations. (B) Brightfield microcopy images and 
representative FACS plots of a pure LEC population. The population is positive for lymphatic markers podoplanin, LYVE-1, and vascular endothelial growth factor 
receptor 3 (VEGFR3). (c) Brightfield microcopy images and representative FACS plots of a pure BEC population. The population is largely negative for lymphatic 
markers podoplanin and LYVE-1, but positive for VEGFR3.
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resUlTs
isolation and characterization of lec  
and Bec from hDMec cultures
Lymphatic endothelial cells and BEC were firstly isolated from 
mixed populations of HDMEC obtained from neonatal foreskins 
of three donors with the aim of obtaining both LEC and BEC 
from the same tissue source. The populations of LEC and BEC 
could be distinguished upon microscopic observation, where 
LEC are visible as island-forming cells within BEC populations 
(Figure  1A). In addition, the two cell types could be distin-
guished by the presence or absence of podoplanin (Figure 1A). 
After immunomagnetic cell sorting into podoplanin-positive 
(LEC) (Figure  1B) and podoplanin-negative (BEC) cells 
(Figure 1C), the purity of the populations was confirmed with 
flow cytometry showing >96% podoplanin-positive and -nega-
tive populations, respectively. In addition, BEC and LEC could 
be distinguished by lymphatic vessel endothelial hyaluronic acid 
receptor (LYVE)-1 expression, while both populations expressed 
VEGFR3 (Figures  1B,C). Populations of LEC and BEC were 
FigUre 2 | Two-dimensional culture of lymphatic endothelial cells (lec) (green), blood vascular endothelial cells (Bec) (red), and adipose-derived 
stromal cells (non-fluorescent). Scale bar represents 200 µm. (a) An overview of the culture showing elongated structures formed by LEC and BEC, and an LEC 
island surrounded by BEC. (B) The same image in larger magnification depicting the different morphologies of BEC and LEC structures, with BEC forming thin, 
uniform projections, and LEC forming both wide and thin structures. (c) The same image in higher magnification showing that structures formed by BEC and LEC 
are separate from each other. LEC were transduced with GFP and BEC with mCherry. LEC and BEC originate from the same human dermal microvascular 
endothelial cells (HDMEC) donor in a single experiment. Images are representative of three experiments with three HDMEC donors.
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transduced with retroviral vectors for stable expression of GFP, 
YFP, or mCherry with the aim of tracking network development 
over several weeks.
2D cultures of lec, Bec, and asc show 
separate lec and Bec Vascular-like 
structures
The three cell types were mixed in equal ratios and observed 
for a period of 1 week to analyze whether LEC and BEC form 
vascular-like structures when cocultured with ASC. The cells 
organized into islands of LEC (green), surrounded by BEC (red) 
(Figure  2A). Both LEC and BEC formed elongated tube-like 
structures that differed in morphology, with LEC forming wide 
structures and BEC thinner ones (Figures 2B,C). In addition, 
the LEC and BEC structures appeared separate from one 
another.
lec respond to increased VegF-c 
concentrations with increased network 
Densities
We next aimed to determine whether LEC cocultured with ASC 
can form networks in fibrin hydrogels. LEC were integrated into 
fibrin matrices together with ASC and cultured for the period of 
28 days. Due to previous observations of our group that VEGF-C is 
not secreted by ASC (Rohringer et al., 2014), different concentra-
tions of VEGF-C were added to the culture medium to determine 
the optimal concentration of VEGF-C for network development 
of LEC. LEC did not form network-like structures without any 
exogenously added VEGF-C (Figure 3A). Some of the structures 
formed were elongated and resembled primitive LEC tubes, but 
the structures were not interconnected. An extensive network 
was already present at day 7 with 10 ng/mL, and the vessel-like 
structures were easily distinguishable. With concentrations of 
25 and 50 ng/mL, the network was dense from day 7, with only 
subtle differences in network density between the two condi-
tions. In addition, we observed that the structure morphology is 
dependent on the VEGF-C concentration. At a concentration of 
10 and 25 ng/mL, the network consists of wider vessel-like struc-
tures, while at 50 ng/mL, the network contains thinner structures 
and these are already present at day 7. The statistical analysis 
shows that the concentration of 10 ng/mL increases the number 
of tubes and junctions significantly compared to the control 
condition of no exogenously added VEGF-C, while this effect 
was even further enhanced at concentrations of 25 and 50 ng/
mL (Figure 3B). The mean number of tubules and junctions at 
0 ng/mL was 72 (±59.22) and 35 (±31.97), at 10 ng/mL was 182 
(±79.92) and 95 (±44.65), at 25 ng/mL was 217 (±88.98) and 119 
(±55.97), and at 50 ng/mL was 218 (±125.9) and 121 (±75.31), 
respectively. In contrast to LEC, culturing BEC with increasing 
concentrations of VEGF-C did not enhance network formation 
(data not shown).
Tricultures of lec, Bec, and asc in Fibrin 
gels show VegF-c-Dependent separate 
network Formation of lec and Bec
Considering the observation that LEC form vascular-like 
networks when cultured with ASC in fibrin hydrogels, we 
next aimed to determine whether LEC and BEC can form 
separate networks and tube-like structures when cocultured 
together in fibrin matrices. Since the concentration of 50 ng/
mL of VEGF-C did not result in significantly denser networks 
compared to 25  ng/mL (Figure  3B), LEC were further cul-
tured in fibrin gels with EGM-2 supplemented with 25 ng/mL 
of VEGF-C. BEC and LEC were integrated, either as mono-
cultures, as cocultures with ASC or as tricultures containing 
LEC, BEC, and ASC. The duplicate samples were cultured in 
EGM-2 medium supplemented with VEGF-C. In the absence 
of ASC, neither BEC nor LEC could form tube-like structures 
or networks (Figure 4A), and the cells grew in monolayers. 
Without VEGF-C, BEC (red) were more prevalent, while with 
the addition of VEGF-C, the LEC (green) and BEC formed 
clearly separated clusters of cells. Both LEC and BEC formed 
networks in the presence of ASC, whereas LEC network for-
mation was more prominent with the addition of exogenous 
VEGF-C. While the mean numbers of LEC tubules and junc-
tions per field in the absence of VEGF-C were 87 (±6.417) 
and 31 (±5.266), respectively, with the addition of VEGF-C, 
the mean numbers of tubules and junctions increased to 450 
(±25.94) and 240 (±15.84), respectively. Without VEGF-C, 
FigUre 3 | effect of increasing vascular endothelial growth factor (VegF)-c concentration on lymphatic endothelial cells (lec) (green) network 
formation in fibrin matrix, when cocultured with adipose-derived stromal cells (asc) for 4 weeks. Scale bar represents 100 µm. (a) Fluorescent images of 
LEC coculture with ASC over a period of 4 weeks, showing that LEC form more extensive networks with the increasing VEGF-C concentration. Images are 
representative of the results of three separate experiments (with three different LEC donors). LEC were transduced with YFP. (B) Quantification of networks 
originating from three different LEC donors, with images of two clots per donor (**p < 0.02, *p < 0.05). Statistical analysis was performed using one-way ANOVA 
and Dunnett’s post hoc test on logarithmically transformed data. All conditions per LEC donor were prepared in duplicate, and one field image was taken from each 
clot and corresponding duplicate.
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the mean number of tubules of BEC was 452 (±46.46) and 
260 (±33.35), respectively, and of junctions was 483 (±52.40) 
and 241 (±29.34), respectively (Figure  4B). LEC and BEC 
networks could also be distinguished by their morphology: 
BEC formed thinner, more uniform structures in comparison 
to the wider and more variable LEC structures (Figures 4A 
and 5A,B). This observation was also confirmed by confocal 
microscopy, where BEC and LEC networks could be clearly 
distinguished in the presence of VEGF-C, while the LEC 
network was close to absent when grown in medium lacking 
VEGF-C (Figures 5C,D).
Direct contact between endothelial cells 
and asc is necessary for the Formation 
of both lymphatic and Blood Vascular 
network-like structures
Adipose-derived stromal cells have been shown previously to 
support vessel formation by endothelial cells in vitro and in vivo 
(Verseijden et al., 2010b; Rohringer et al., 2014; Holnthoner et al., 
2015). Additionally, ASC-CM was shown to have a beneficial 
effect on the migration, proliferation, and network formation of 
endothelial cells (Merfeld-Clauss et  al., 2010; Verseijden et  al., 
FigUre 4 | network formation and quantification of coculture of lymphatic endothelial cells (lec) (green) and blood vascular endothelial cells (Bec) 
(red) in fibrin matrices when cultured in the presence or absence of adipose-derived stromal cells (asc), and exogenous vascular endothelial 
growth factor (VegF)-c (25 ng/ml), during the period of 4 weeks. Scale bar represents 100 µm. (a) Overlays of fluorescent images of cocultures show the 
network formation of LEC and BEC in the presence of ASC. The addition of exogenous VEGF-C results in a denser LEC, but not BEC networks. There is no network 
formation of LEC or BEC without ASC. Images are representative of data from two experiments with two separate human dermal microvascular endothelial cells 
(HDMEC) and ASC donors. The LEC were transduced with GFP and BEC with mCherry. (B) Network quantification data show that there is a significant increase in 
the number of tubules and junctions of LEC cultured with ASC when the medium was supplemented with VEGF-C (25 ng/mL), compared to when cultured in 
EGM-2 medium without VEGF-C. BEC do not show a significant difference in the number of junctions or tubules between the two conditions. **p < 0.02, LEC 
cultured in EGM-2 vs. in EGM-2 + 25 ng/mL VEGF-C; BEC cultured in EGM-2 vs. in EGM-2 + 25 ng/mL VEGF-C. Data originate from two experiments with two 
HDMEC and two ASC donors.
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2010b; Rohringer et al., 2014). However, direct cell–cell contact 
was shown to be essential for full network and tube formation 
(Rohringer et  al., 2014). To examine whether ASC-CM had a 
similar effect on LEC and BEC network formation as co-culturing, 
these cells with ASC, LEC, and BEC were embedded in fibrin 
hydrogels and incubated in ASC-CM. The medium was gener-
ated by culturing ASC in EGM-2 for 48 h prior to applying the 
medium onto LEC and BEC. The cells were also cultured in the 
FigUre 5 | lymphatic endothelial cells (lec) (green) and blood 
vascular endothelial cells (Bec) (red) form two separate networks in 
cocultures with adipose-derived stromal cells. Scale bar represents 
100 µm. (a,B) Overlays of fluorescent images showing that BEC and LEC 
form two separate networks and that upon addition of exogenous vascular 
endothelial growth factor (VEGF)-C, LEC network becomes increasingly 
dense. (c,D) Merged Z-stacks taken with confocal microscope showing that 
without exogenous VEGF-C, there is limited proliferation and network 
formation of LEC, while in the presence of VEGF-C (25 ng/mL), LEC develop 
an extensive network that is separate from the BEC network. LEC were 
transduced with GFP and BEC with mCherry.
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presence of ASC to control for the network-forming capacity of 
BEC and LEC. LEC were grown with the addition of VEGF-C 
(25 ng/mL), as this was shown to lead to network formation in 
coculture with ASC. When cultured with ASC, both LEC and 
BEC showed network formation by day 14 of culture (Figure 6). 
LEC showed more extensive network formation upon the addi-
tion of VEGF-C. There was, again, no effect of VEGF-C on 
the network formation of BEC. When cultured without ASC 
in EGM-2 medium, neither LEC nor BEC displayed network 
formation. With the addition of VEGF-C, LEC proliferated 
and formed a monolayer. BEC started forming some elongated 
structures, but no network formation could be observed. When 
the cells were cultured in ASC-CM, there was again no network 
formation, and the cells grew similarly to their respective coun-
terparts in unconditioned EGM-2 medium. While BEC formed 
some elongated structures, they were not able to form a network 
by day 14. LEC again proliferated in the presence of VEGF-C and 
grew in a monolayer, while without VEGF-C, the cells started 
to elongate but could not form a network. Since we did not 
observe full network formation in the conditions without ASC, 
these networks could not be quantified and further subjected to 
statistical analysis.
DiscUssiOn
Integration of both blood and lymphatic vasculature into tissue-
engineered constructs can be crucial for the long-term viability 
and survival of such constructs in  vivo. In this study, separate 
blood and lymphatic microvascular structures were successfully 
created in a 3D in vitro model using BEC and LEC derived from 
human dermis. We could follow the network development over 
time by fluorescently labeling the two cell populations, which 
represents a novel approach in studying lymphangiogenesis and 
vasculogenesis in vitro.
Since the human dermal microvascular fraction consists of 
both BEC and LEC, the two cell populations were firstly isolated 
separately, before being used in further cocultures. LEC can be 
distinguished from BEC by the presence of LEC-specific markers 
such as podoplanin, LYVE-1, prospero homeobox (Prox)-1, and 
VEGFR3 (Kaipainen et al., 1995; Banerji et al., 1999; Breiteneder-
Geleff et al., 1999; Wigle et al., 2002; Cueni and Detmar, 2006). 
Podoplanin was chosen as a suitable lymphatic marker, as it has 
been used previously to isolate LEC from a mixed population con-
taining LEC and BEC (Kriehuber et al., 2001; Makinen et al., 2001) 
due to its almost exclusive expression on lymphatic endothelium 
(Carreira et al., 2001; Florez-Vargas et al., 2008) and preferential 
staining of the smaller diameter LEC vessels (Galambos and 
Nodit, 2005). Immunomagnetic separation of HDMEC based 
on this marker resulted in a >96% pure podoplanin-negative 
and -positive populations (Figures  1B,C), where the positive 
population was expressed LYVE-1, which was not present in the 
podoplanin-negative BEC population (Figures 1B,C). Although 
VEGFR3 is a lymphatic endothelium-specific marker, our obser-
vations of a VEGFR3-positive BEC population is in accordance 
with previous data by Kriehuber et al. (2001) who also showed the 
presence of VEGFR3 on some BEC, albeit to a lesser extent than 
shown here. The purity of the populations is of great importance 
for showing the separate network formations of BEC and LEC.
Lymphatic endothelial cells and BEC populations were 
transduced with fluorescent proteins and cultured together with 
ASC for a period of 4 weeks to follow the progress of network 
formation over time. ASC have been shown previously to support 
vasculogenesis by secretion of pro-vasculogenic factors and direct 
cell–cell contact (Verseijden et al., 2010b; Rohringer et al., 2014; 
Holnthoner et al., 2015; Merfeld-Clauss et al., 2015). In addition, 
ASC support the migration, proliferation, and tube formation of 
LEC, again through direct contact and the secretion of growth 
factors, such as VEGF-A, VEGF-D, fibroblast growth factor-2, 
hepatocyte growth factor, and angiopoietin-1 (Hsiao et al., 2012; 
Takeda et al., 2015; Strassburg et al., 2016). Since there is contro-
versy in literature regarding the secretion of VEGF-C by ASC in 
cocultures with endothelial cells (Rohringer et al., 2014; Takeda 
et al., 2015; Strassburg et al., 2016), the cocultures of LEC, BEC, 
and ASC were supplemented with 25  ng/mL VEGF-C, which 
had been shown previously to support LEC proliferation and 
network formation (Podgrabinska et  al., 2002; Boardman and 
Swartz, 2003; Marino et al., 2014; Gibot et al., 2016). Our results 
support these observations. Here, we show that LEC and BEC 
form elongated structures in the presence of ASC and VEGF-C 
even in the 2D coculture, and these structures were observed to 
FigUre 6 | The effect of asc-conditioned medium (asc-cM) on the network formation of lymphatic endothelial cells (lec) (green) and blood 
vascular endothelial cells (Bec) (red). Scale bar indicates 100 µm. The first row shows successful network formation of both LEC and BEC when cultured with 
adipose-derived stromal cells (ASC) in EGM-2 medium. The LEC network formation is enhanced upon the addition of vascular endothelial growth factor (VEGF)-C. In 
the middle row, LEC and BEC were cultured in monocultures in EGM-2 medium, with or without added VEGF-C, which resulted in no network formation of either 
cell types. In the bottom row, the cells were cultured in the ASC-CM, which, similarly to unconditioned EGM-2, resulted in no network formation of LEC or BEC. 
Images were taken at day 14 of culture. LEC were transduced with mCherry and BEC with GFP. Images are representative of two experiments with two HDMEC 
donors.
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be separate from each other. In addition, the distinction between 
LEC and BEC structures could be found in their morphology, 
as LEC formed structures of variable width, while BEC joined 
into thin, more uniform projections (Figure 2). Based on these 
observations, we proceeded to integrate LEC, BEC, and ASC into 
fibrin matrices to observe the network formation in 3D. Fibrin 
was chosen as a natural product of the blood coagulation cascade 
(Davie et  al., 1991) and as suitable scaffold material as it has 
been described previously to facilitate successful vasculogenesis 
(Rohringer et al., 2014; Holnthoner et al., 2015). Without ASC, 
both LEC and BEC formed a monolayer and did not arrange 
even into primitive tube-like structures. Coculturing of both LEC 
and BEC with ASC had a positive effect on the network forma-
tion, while this effect was more apparent for BEC than for LEC 
when grown in EGM-2 medium without exogenous VEGF-C. 
VEGF-C significantly enhanced the network formation of LEC 
in cocultures with ASC, but not of BEC, indicating that VEGF-C 
is essential for the network formation of LEC and that, even if 
secreted by ASC, the amounts are not sufficient to promote 
network formation of LEC. Kazenwadel et  al. (2012) showed 
that VEGF-C promotes lymphatic vessel elongation in studies 
of embryonic mouse LEC, but that, in cooperation with FGF-2, 
the vessels also grow in diameter. Although we did not measure 
the vessel diameter, the fluorescent images of LEC grown in dif-
ferent VEGF-C concentrations suggest there are some structural 
differences between low and high VEGF-C concentrations. The 
seemingly widest structures, resembling the ones shown by 
Kazenwadel et al. (2012), are present mostly under the conditions 
lacking VEGF-C, or at 10 ng/mL. Such differences are not observ-
able in BEC networks, which form similarly dense networks at all 
concentrations of VEGF-C (data not shown). Most importantly, 
the two separate endothelial cell populations clearly form two 
separate networks, lacking a “mosaic” phenotype between LEC 
and BEC. These observations, together with our flow cytometry 
data, which support the purity of fluorescent BEC and LEC popu-
lations, demonstrates that two separate networks can be formed 
from the same dermal endothelial cell source. Kriehuber et  al. 
(2001) also showed separate capillary tube formation by LEC and 
BEC when cultured together on Matrigel. Marino et  al. (2014) 
reported the formation of two separate networks when HDMEC 
were cultured in fibrin hydrogels by staining the networks against 
CD31 and the lymphatic marker Prox-1. Their model has also 
shown successful anastomosis of engineered vasculature with 
the rat host vasculature in vivo (Marino et al., 2014). Helm et al. 
cocultured BEC and LEC in a 3D matrix consisting of collagen 
and fibrin with covalently bound VEGF. They, furthermore, 
applied interstitial flow in order to enhance capillary formation 
(Helm et  al., 2007). The positive effect of interstitial fluid flow 
on LEC migration was also investigated on an in  vivo mouse 
tail model (Boardman and Swartz, 2003) and in vitro by using 
a multichamber fluidic device (Ng et al., 2004). Strassburg et al. 
cocultured ASC and LEC in  vitro in Matrigel to achieve tube 
formation. However, no fully connected lymphatic network was 
observed (Strassburg et al., 2016). Matrigel is a not well-defined 
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matrix derived from Engelbreth-Holm-Swarm tumors in mice 
(Hughes et al., 2010). Therefore, non-tumor-derived autologous 
scaffolds, such as fibrin, are a more feasible and adequate matrix 
for pre-vascularization strategies. Considering the recent devel-
opments in engineering lymphatic microcapillaries, the data 
presented here build upon the current knowledge of blood and 
lymphatic microvasculature formation and offer a valuable 3D 
model that can be followed during a period of 4 weeks.
Finally, we aimed to investigate whether direct contact 
between ASC and LEC or BEC was necessary for the development 
of vascular networks, since ASC have been shown previously to 
support the vessel formation of endothelial cells (Verseijden 
et  al., 2010b; Rohringer et  al., 2014; Holnthoner et  al., 2015). 
Additionally, ASC-CM was shown to have a beneficial effect on 
endothelial cell migration, proliferation, and network formation 
(Merfeld-Clauss et al., 2010; Verseijden et al., 2010b; Rohringer 
et al., 2014). Since lymphatic capillaries are not surrounded by 
mural cells (Swartz and Skobe, 2001), we investigated whether 
LEC could develop into a fully established lymphatic capillary 
network in the presence of ASC-CM. In line with previous find-
ings (Verseijden et al., 2010b; Rohringer et al., 2014), we did not 
observe network formation when LEC or BEC were cultured 
in ASC-CM, suggesting that cell–cell interaction or even direct 
contact is necessary for the development of both lymphatic and 
blood microcapillaries. It is, therefore, possible that while the 
development of lymphatic capillaries depends on direct contact 
with supporting cells, LEC, once developed, do not require sup-
port from pericytes for maintenance of the vessels.
Pre-vascularization of tissue-engineered constructs requires 
autologous sources of endothelial cells. Outgrowth endothelial 
cells can be isolated from peripheral blood (Fuchs et al., 2009) and 
have shown network-forming capacities in cocultures with ASC 
(Fuchs et al., 2009; Medina et al., 2010; Holnthoner et al., 2015). 
LEC were also suggested to be present in peripheral blood (Szöke 
et al., 2015) and have also been obtained previously from induced 
pluripotent stem cells (Lee et al., 2015). Interestingly, preliminary 
data from our group showed that combinations of LEC derived 
from human lymph nodes in triculture with ASC and HUVEC 
formed separate vascular networks, too (data not shown). One 
limitation of our study is the use of HDMEC as a source for both 
LEC and BEC, which is not a clinically applicable source of these 
cells. The use of potentially autologous cells in our model would 
represent an important step toward pre-vascularization of tissue-
engineered constructs. Moreover, the endothelium is a highly 
heterogeneous organ. In this study, we used ECs from human 
foreskin, which represent a “golden standard” for microvascular 
ECs. However, ECs from other tissues possibly lead to different 
results, thereby limiting the conclusions of our data. Furthermore, 
it is difficult to assess the presence of the vascular lumen in the 
networks in our experimental setting. However, we have shown 
previously the presence of perfusable, lumen-containing struc-
tures in networks of outgrowth endothelial cells cocultured with 
ASC in fibrin hydrogels in vivo (Pill et al., 2015). While recent 
studies report the culture of the networks for a period of 24 h 
up to 10 days (Podgrabinska et al., 2002; Ng et al., 2004; Helm 
et al., 2007; Kazenwadel et al., 2012), we show here that the two 
separate networks are sustainable over the period of 4  weeks. 
Furthermore, our data show that network density of endothelial 
cells in co- and tricultures increases over time. Implantation of 
lymphatic and blood vascular networks in fibrin hydrogels, e.g., 
in a nude mouse model will shed more light on the functionality 
of our model in vivo.
Our 3D model contributes to the reemerging field of lym-
phatic tissue engineering, and it also represents a useful model 
for studying the pathogenesis of this system. In addition, the scaf-
fold containing both the lymphatic and blood vascular networks 
could be used to study the influences of various angiogenic and 
lymphangiogenic drugs on the development and interactions of 
the two systems in  vitro. Furthermore, engineering lymphatic 
microvasculature would be a valuable addition to microphysi-
ological systems used for drug development and diagnostics 
(Muehleder et  al., 2014; Tien, 2014; Hasenberg et  al., 2015). 
Attempts to generate an artificial lymphatic drainage system on 
a chip have been made; however, the incorporation of LEC in 
such a system is currently unprecedented (Wong et  al., 2013). 
Importantly, the integration of blood and lymphatic microcapil-
laries could enhance the survival of the tissues incorporated in 
the chips and, furthermore, contribute to a better recapitulation 
of physiological conditions (Muehleder et al., 2014; Tien, 2014). 
Considering the in vivo validation and acquisition of BEC and 
LEC from a potentially autologous source, our model could serve 
as a pre-vascularization strategy of both blood and lymphatic 
systems leading to improved survival and functionality of engi-
neered tissues.
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